• Explore /
  • Poster
  • / A phase I study of oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer.

A phase I study of oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer.

Abstract Poster

Authors

Cullen Taniguchi

Cullen M. Taniguchi

Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Cullen M. Taniguchi , Sonal S Noticewala , Cara L. Haymaker , Prajnan Das , Ethan B. Ludmir , Anirban Maitra , Shubham Pant

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies

Sub Track

Other Therapeutic Interventions

Clinical Trial Registration Number

NCT04193904

Citation

JCO Global Oncology 9, 2023 (suppl 1; abstr 58)

DOI

10.1200/GO.2023.9.Supplement_1.58

Abstract #

58

Poster Bd #

D5

Abstract Disclosures

Similar Posters

First Author: Mustafa Basree

First Author: Andrew Oar

First Author: Yusuke Hashimoto

First Author: Samhita Chakraborty